Literature DB >> 15039542

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus.

Kiyoko Iwatsuki-Horimoto1,2, Rie Kanazawa3, Shunji Sugii3, Yoshihiro Kawaoka4,1,2, Taisuke Horimoto1,2.   

Abstract

To gain insight into the events that occur when avian influenza viruses are transmitted to humans, the receptor-binding properties of the index H5N1 influenza virus isolated from a human in 1997 and the A/turkey/Ontario/7732/66 (H5N9) virus were compared, by using a haemadsorption assay. Cells expressing the haemagglutinin (HA) of the human isolate were adsorbed by both chicken red blood cells (RBCs) and human RBCs; those expressing the avian virus HA were only adsorbed by chicken RBCs. These results indicate that human and avian influenza virus H5 HAs differ in their recognition of sialyloligosaccharides on the RBCs of different animal species. Mutational analyses indicated that differences in both the oligosaccharide chains and in the amino acid sequences around the HA receptor-binding site were responsible for this difference in receptor binding. These data further support the concept that alteration in receptor recognition is important for replication of avian viruses in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039542     DOI: 10.1099/vir.0.19519-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak in poultry in India.

Authors:  Koninika Ray; Varsha A Potdar; Sarah S Cherian; Shailesh D Pawar; Santosh M Jadhav; Shamal R Waregaonkar; Anshu A Joshi; Akhilesh C Mishra
Journal:  Virus Genes       Date:  2008-01-24       Impact factor: 2.332

Review 2.  Viral zoonoses in Europe.

Authors:  Hannimari Kallio-Kokko; Nathalie Uzcategui; Olli Vapalahti; Antti Vaheri
Journal:  FEMS Microbiol Rev       Date:  2005-06-29       Impact factor: 16.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.